The purpose of this RFP is to solicit consulting services for a hypothetical company Cure& Pharma Inc. to help the company launch its new vaccine program across the globe.
Our team helped the partner in the pursuit by coming up with a presentation/deck that has PwC analysis on the situation and value that can be delivered by PwC in a future engagement.
Based on the prevailing and predicted growth pattern of the virus, we conducted an effective market analysis of the highly affected geographies to assess suitability, demand, profitability, and other situational factors that might affect Cure& decision to enter/focus on a specific market/geography. Also devise an effective strategy for delivering the vaccine taking into account socioeconomic and demographic factors such as age, income, comorbidities, etc.
We provided an industry outlook for Pharma Contract (Third Party Mfg.) Manufacturing. Discuss parameters like industry size, growth rate, geographical spread, risks etc.
In our discussion with existing contract manufacturers for other products, it was determined that they may not have the capabilities and capacity to manufacture BT1479. Articulate parameters to be considered while evaluating other manufacturing & distribution partners in the following areas: -
- Suppliers for sourcing of Active Pharmaceutical Ingredients (APIs)
- Third-Party Manufacturers
- Third-party logistics providers
Considering the impact of the Covid-19 crisis and the potential launch of the Covid-19 vaccine, we assessed the impact on the Financial Planning and Budgeting process performed by the Finance Department. Determine the drivers (key factors) that will be used in the future for the Planning and Budgeting Process.